Physician profile
Jacob M Ringenberg
NPI 1336433010
$736.72
in general payments reported to CMS, 2019-2025
22 companies · $50.16 in 2025
The $50.16 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $106 · 2021: $93.80 · 2022: $104 · 2023: $21.42 · 2024: $33.17 · 2025: $50.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $135.30 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $106.29 | 2020 | |
| Ge Healthcare | $74.57 | 2021-2023 | |
| Mylan Specialty L.P. | $46.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.11 | 2019 | |
| Lilly USA, LLC | $34.61 | 2019 | |
| Merck Sharp & Dohme LLC | $34.47 | 2019 | |
| Arbor Pharmaceuticals, INC. | $29.97 | 2019 | |
| Hydrocision, INC. | $25.84 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.60 | 2025 | |
| Amgen INC. | $23.98 | 2019 | |
| Sanofi Pasteur INC. | $16.95 | 2019 | |
| Abbvie INC. | $16.30 | 2021 | |
| Daiichi Sankyo INC. | $15.46 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $15.13 | 2019 | |
| Allergan, INC. | $13.38 | 2019 | |
| Glaxosmithkline, LLC. | $12.94 | 2022 | |
| Organon LLC | $12.82 | 2024 | |
| Duchesnay USA Incorporated | $11.87 | 2019 | |
| Novo Nordisk INC | $11.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Ringenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.